Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 23, 2015
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort
Oliver Gautschi, Julie Milia, Bastien Cabarrou, et al.
Frontiers in Immunology
|
July 16, 2026
Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14)
Yannik da Silva, Dapi Menglin Chiang, Laura Benecke, et al.
Journal for Immunotherapy of Cancer
|
February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 25, 2018
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma
Yannis Metaxas, Gareth Rivalland, Laetitia A Mauti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial
Sacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.
The European Respiratory Journal
|
August 12, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Myriam Delaunay, Jacques Cadranel, Amélie Lusque, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2019
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial
Miguel-Angel Molina-Vila, Rolf A Stahel, Urania Dafni, et al.
Oncology
|
May 21, 2026
Decision making in intrathecal therapy for leptomeningeal disease
Susanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul M Putora, Markus Glatzer, José Belderbos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 25, 2019
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 23, 2015
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort
Oliver Gautschi, Julie Milia, Bastien Cabarrou, et al.
Frontiers in Immunology
|
July 16, 2026
Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14)
Yannik da Silva, Dapi Menglin Chiang, Laura Benecke, et al.
Journal for Immunotherapy of Cancer
|
February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 25, 2018
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma
Yannis Metaxas, Gareth Rivalland, Laetitia A Mauti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial
Sacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.
The European Respiratory Journal
|
August 12, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Myriam Delaunay, Jacques Cadranel, Amélie Lusque, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2019
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial
Miguel-Angel Molina-Vila, Rolf A Stahel, Urania Dafni, et al.
Oncology
|
May 21, 2026
Decision making in intrathecal therapy for leptomeningeal disease
Susanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul M Putora, Markus Glatzer, José Belderbos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 25, 2019
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Page
of 10